Krishna Institute of Medical Sciences (NSE:KIMS) DeferredTaxAndRevenue: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:KIMS Krishna Institute of Medical Sciences Ltd NSE:KIMS
87 GF Score
Price ₹797.85
GF Value ₹793.22
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Krishna Institute of Medical Sciences DeferredTaxAndRevenue?

Krishna Institute of Medical Sciences NSE:KIMS +2.09% 87 DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:KIMS with a GF Score™ of 87/100 and a GF Value™ of ₹793.22 (Fairly Valued). The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Krishna Institute of Medical Sciences's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ₹0 Mil.

Krishna Institute of Medical Sciences DeferredTaxAndRevenue Related Terms

Krishna Institute of Medical Sciences DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Krishna Institute of Medical Sciences's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krishna Institute of Medical Sciences DeferredTaxAndRevenue Chart

Krishna Institute of Medical Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
DeferredTaxAndRevenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Krishna Institute of Medical Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:KIMS
87GF Score
Krishna Institute of Medical Sciences Ltd NSE:KIMS
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ₹0 Mil mean?
Krishna Institute of Medical Sciences (NSE:KIMS) has a DeferredTaxAndRevenue of ₹0 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Krishna Institute of Medical Sciences.
Is Krishna Institute of Medical Sciences' DeferredTaxAndRevenue too high?
Krishna Institute of Medical Sciences' current DeferredTaxAndRevenue is ₹0 Mil. Overall, Krishna Institute of Medical Sciences has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Krishna Institute of Medical Sciences' DeferredTaxAndRevenue compare to HCA and THC?
Krishna Institute of Medical Sciences' DeferredTaxAndRevenue of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Krishna Institute of Medical Sciences. Krishna Institute of Medical Sciences's current DeferredTaxAndRevenue is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krishna Institute of Medical Sciences stock overvalued right now?
Based on GuruFocus' analysis, Krishna Institute of Medical Sciences (NSE:KIMS) is currently considered Fairly Valued. The stock's GF Value™ is ₹793.22, compared to a current price of ₹797.85 — trading 0.6% above its estimated fair value. The current DeferredTaxAndRevenue is ₹0 Mil. Krishna Institute of Medical Sciences' overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Krishna Institute of Medical Sciences (NSE:KIMS), the current DeferredTaxAndRevenue is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krishna Institute of Medical Sciences (NSE:KIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Krishna Institute of Medical Sciences stock appears to be overvalued. The current stock price of ₹797.85 is trading 0.6% above its estimated GF Value™ of ₹793.22. GuruFocus considers Krishna Institute of Medical Sciences to be Fairly Valued.

Key valuation signals for NSE:KIMS:

  • DeferredTaxAndRevenue: ₹0 Mil
  • GF Value™: ₹793.22 vs. price of ₹797.85 (0.6% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the NSE:KIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krishna Institute of Medical Sciences Business Description

Other Exchanges 543308:India
Address D. No. 1-8-31/1, Minister Road, Secunderabad, TG, IND, 500 003
Krishna Institute of Medical Sciences Ltd is a healthcare group in Secunderabad and Telangana. It offers a comprehensive range of healthcare services, including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, mother and child care, and many more. The firm generates key revenue from Hospital services and Pharmacy.
87GF Score

Get the complete analysis for NSE:KIMS

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹797.85
Price
₹793.22
GF Value